Pediatric Vaccine for COVID-19 Part 2: Update on the Vaccine for 5-11-yrs, Boosters, and Omicron

In part 2 of this World Shared Practice Forum podcast, Dr. Paul Offit, Professor of Pediatrics in the Division of Infectious Disease and the Director of the Vaccine Education Center at The Children's Hospital of Philadelphia, updates listeners on the latest data in the field of COVID vaccination. He summarizes results from Pfizer’s phase 3 vaccine trial involving 5- to 11-year olds, and discusses the considerations behind the recommendation of a third "booster" vaccine dose for all eligible age groups. He also explains what is known about COVID virus variants, including Omicron.

Learning Objectives: After listening to this podcast, learners will be able to: -Describe the basic structure and results of the Pfizer COVID vaccine trial involving five- to eleven-year-old children -Discuss the potential benefits of a third "booster" dose of COVID vaccine for different patient populations -Describe the risks of myocarditis and other inflammatory syndromes associated with COVID infection, and possibly with COVID vaccines -Compare the clinical characteristics of the emerging Omicron variant to earlier variants of the SARS-CoV-2 virus

Articles referenced: • Offit PA. You Bet Your Life: From Blood Transfusions to Mass Vac…

Original video:
Downloaded by on Mon Jan 3 22:29:28 2022 Available for 30 days after download